Trial · NCT05684276
DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors
NCT05684276, Phase 2, Active not recruiting, Fundación GECP
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors. Trials, record NCT05684276. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05684276
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors
- NCT number
- NCT05684276
- Status
- Active not recruiting
- Phases
- Phase 2
- Enrollment
- 22 participants, estimated
- Lead sponsor
- Fundación GECP
- Conditions
- NSCLC, Pancoast Tumor
- Interventions
- Carboplatin, Paclitaxel, Nivolumab
- First posted
- 2023-01-13
- Last updated
- 2026-05-05
- Other registries' IDs
- eudract:2022-003717-11
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Estimate progression-free survival (PFS) | From the date randomization until the date of last follow up, assessed up to 24 months | The PFS is defined as the time from diagnosis to relapse, progression or death, whichever occurred first |
| Secondary | Overall survival | From the date of randomization until the date of last follow up, assessed up to 24 months | The length of time from either the date of diagnosis or the start of the treatment that patients diagnosed with the disease are still alive. |
| Secondary | Incidence of Treatment-Emergent Adverse Events (Safety and Tolerability) | From the subject's written consent to participate in the study through 100 days after the final administration of the drug | It will be measured by the incidence of AE, SAE, immune-related AEs, deaths, and laboratory abnormalities. Adverse events will be graded according to CTCAE v5.0 |
| Secondary | Complete resection (R0) rate | From the date of completion of induction treatment until the date of last follow up, assessed up to 24 months | Defined as the time between the date of randomization and the date of death |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05684276
GET https://conductscience.org/api/trials/v1/NCT05684276/registered